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Abstract
Percutaneous stone surgery is the gold standard in removing large renal calculi. In light of the increase in
prevalence and size of renal stones being addressed in recent years, numerous advances have been made in
attempts of improving the morbidity, efficacy, and technical ease of stone clearance. In this review article,
we assess new advancements in percutaneous stone surgery including diagnosis and surgical planning,
methods of renal access, patient positioning, tract dilation, nephroscopes, lithotripsy, and post-operative
drainage and antibiotic prophylaxis.
© 2016 Pan African Urological Surgeons’ Association. Production and hosting by Elsevier B.V. All rights reserved.
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Nephrolithiasis is an increasingly common condition that is the
global cause of a significant amount of morbidity. Burgeoning rates
of conditions such as hypertension, obesity, and diabetes mellitus
have contributed to the rise in incidence of new stones. Within
the past two decades, for instance, the prevalence of diabetes has
increased two fold; along with it, the frequency of stone-related
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1110-5704/© 2016 Pan African Urological Surgeons’ Association. Production anmergency Department visits has also risen from 178 in 100,000
isits to 340 in 100,000, nearly doubling in number [1,2]. Over time,
n increase in the absolute size of stones diagnosed has increased
s well.
n addition to medical comorbidities and genetic factors, environ-
ental factors have been suggested to affect rates of nephrolithiasis
s well. It has been demonstrated that the development and compo-
ition of stones within the in Chinese-American community differs
rom those of the Chinese. Chi et al. [3] has found that Chinese-
mericans are more likely to have higher body mass indices (BMIs)
nd develop stones an average of 9 years earlier than individuals in
hina.ercutaneous nephrolithotomy (PCNL) became a standard tech-
ique to address complex, large renal stones during the last two
d hosting by Elsevier B.V. All rights reserved.
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ecades of the twentieth century [4]. Given its decreased morbidity,
ower cost, and shorter duration of hospitalization compared to open
ephrolithotomy, PCNL has rendered open stone extraction obso-
ete [5]. In an era when the demographics of the general populace
re leading to the production of larger stones in unhealthier patients,
CNL is more relevant than ever.
e aim to review the PCNL literature and evaluate the most recent
dvances in techniques in percutaneous stone surgery.
iagnosis
mong imaging studies used to diagnose nephrolithiasis including
ltrasound (US) and plan X-ray films, computerized tomography
CT) has been accepted as the standard for pre-operative stone eval-
ation. CT is highly sensitive for diagnosing nephrolithiasis, easy
o quickly obtain, and cost-effective [6]. In patients with a signifi-
ant stone burden, CT assists in categorizing stone size, density, and
ocation within the collecting system. CT is also extremely helpful
n determining the approach for access into the kidney. If a concern
ver radiation exposure exists, a low-dose CT can be considered.
S can reasonably diagnose renal stones as well, although with a
ensitivity and specificity lower than that of CT [7].
ost recently efforts have been made to risk stratify patients with
ephrolithiasis based on pre-operative imaging. One example is
he S.T.O.N.E nephrolithotomy scoring system that measures five
haracteristics reflecting stone complexity on CT: stone size (S),
ract length (T), obstruction (O), number of calyces involved (N),
nd “essence” or stone density (E). In an initial study at a single
nstitution examining 117 patients, it was noted that the S.T.O.N.E
core can be used to estimate operative time, estimated blood loss
EBL), stone-free rates, and length of stay (LOS) [8]. In a follow-
p study, the original authors validate the use of the S.T.O.N.E
core in a multi-institutional trial that confirms their initial find-
ngs: the higher a patient’s score, the lower a patient’s stone-free
ate, the longer the bleeding time and greater the EBL, the longer
he operative time, LOS, fluoroscopy use, and the higher the rate of
ost-operative complications [9]. Other examples of stone scoring
ystems include the Guy’s stone score and the Clinical Research
ffice of the Endourological Society (CROES) nomogram. In com-
aring these three scoring systems, Labadie et al. [10] found that
espite their differences, they all were able to predict stone-free
tatus of patients.
ll of these scoring systems enhance the ability of the surgeon
o effectively plan for a percutaneous stone procedure and effec-
ively counsel patients. Each system has its advantages, and we
ecommend use of one in an effort to streamline risk stratification
mong patients and assist surgeons in standardizing the dialog of
he severity of a patient’s condition across institutions.
reoperative  planning
he proliferation of long-term anticoagulation and antiplatelet ther-
py has followed the increased use of drug-eluting cardiac stents,
echanical heart valves, and therapy for atrial fibrillation [11,12].
esultantly, the pool of patients requiring PCNL who require these
ypes of medications has increased as well. The length of time a
atient may be safely off anticoagulation peri-operatively as well as
ow to address stones in those patients in whom anticoagulation may
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ot be suspended has not been clearly established. Patients who are
oo high risk to discontinue anticoagulation for any period of time
ay benefit from staged ureteroscopic procedures in lieu of PCNL.
n high risk cardiac patients, cessation of aspirin may adversely
ffect cardiac outcomes due the consequential rebound effect. The
iterature, however, suggests that aspirin can be safely continued
eri-operatively in PCNLs without any significant increased risk of
leeding [13,14].
urrently, it is recommended that patients on anticoagulation under-
oing procedures that carry a high risk of bleeding, like PCNL,
uspend warfarin use 3–5 days before that date of the planned
rocedure. One study has recommended specifically in PCNL that
arfarin be discontinued 5 days before surgery and not resumed until
 days post-operatively. In addition, low molecular weight heparin
ay be used to bridge patients during the period of withholding oral
ntiplatelet agents. These actions carry a risk of major bleeding of
%, an acceptable value [15].
n addition to post-operative hemorrhage, sepsis from a urinary tract
ource is a morbid complication of PCNL that can lead to death.
eliberate steps should be taken during pre-operative evaluation
y obtaining a urinalysis and urine culture (Ucx) to minimize the
isk of developing this condition. Gutierrez et al. [16] assessed 5354
atients who underwent PCNL who had pre-operative urine cultures
vailable. Findings suggested that 865 (16.2%) of study participants
xhibited a positive urine culture, and of those patients with a pos-
tive culture, 18.2% developed fevers post-procedure compared to
.8% of patients with a negative pre-operative culture. Moreover,
n patients with infections caused by Enterobacter  species, 23.8%
eveloped a fever, as compared to only 9.7% of those with Staphy-
ococcus  species infections, suggesting different levels of virulence
mong bacterial species. When patients display a contaminated
rine culture, pre-operative preparation becomes more nebulous.
eavitt et al. [17] has shown that in 291 patients with a negative
rinalysis or urine dipstick analysis, none developed post-operative
epsis after PCNL. These findings infer that negative results of these
ests may be sufficient in surgical planning; however, we support
ecommendations that a urine culture prior to PCNL is optimal to
inimize the risk of sepsis.
he best predictors of post-PCNL sepsis have been stone cultures or
ultures from the renal pelvis [18]. Despite negative urine cultures,
tones may harbor bacteria, and even in the absence of active infec-
ions, stone fragmentation releases pre-formed bacterial endotoxins
hat increase the risk of sepsis [19]. Larson et al. [20] has com-
ared stone cultures (Scx) and Ucx in patients undergoing PCNL
nd has found that Scx and Ucx correlate in 79% of cases. In patients
ith negative Ucx, Scx was positive in 12.5% of cases. Resultantly,
hey recommend routinely obtaining Scx to assist in appropriately
ailoring antibiotics if a patient were to develop sepsis.
he duration of antibiotic therapy in patients undergoing PCNL
reoperatively is also debatable. Studies have previously indicated
hat high risk patients may benefit from seven days of pre-operative
ntibiotic therapy even in the setting of a negative urine culture
o reduce the risk of sepsis. Administering two versus seven days
f pre-operative antibiotic prophylaxis in this cohort of patients
as recently assessed [21]. Results displayed that the course of
ntibiotic therapy in the setting of a negative urine culture had
o effect on fevers >38.5 ◦C, systemic inflammatory response syn-
rome (SIRS) symptoms, or rates of post-procedure sepsis. Either
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two or seven days of antibiotic prophylaxis is effective in treating
high risk patients pre-PCNL with negative urine cultures.
Access
Renal access during PCNL can be achieved prior to the proce-
dure with the placement of a nephrostomy tube by interventional
radiology (IR), or by the urologist at the time of definitive stone
management. The decision to obtain access via either route is based
on both physician preference and experience; surgeons who per-
form less PCNLs may opt for pre-operative IR access, whereas
endourologists would be more comfortable gaining access them-
selves. Differences in IR access and access obtained at the time of
PCNL have been studied to elucidate any variations in outcomes and
stone-free rates between each method [22]. It has been noted that
urologists are much more likely to achieve access in the 10th or 11th
intercostal spaces than interventional radiologists (47% vs. 14%,
p  < 0.01). Patients who underwent pre-procedure access with inter-
ventional radiology were significantly more likely to necessitate
secondary procedures to become stone-free (38 vs. 21%, p  < 0.01).
No difference was observed in the complication rate between each
group, including failed access, transfusion, or a clinically significant
pneumothorax or hemothorax requiring intervention. In summary,
access may be safely obtained by either interventional radiologists
or urologists. The data supports the conclusion that when a urolo-
gist gains access at the time of PCNL, he/she is more likely to only
perform one procedure before the patient is deemed stone-free. We
can attribute this success in part due to the strategic access points an
endourologist pursues to best remove the entire stone burden instead
of simply gaining entry into the collecting system for drainage.
In an effort to curb the length of fluoroscopy time and radiation expo-
sure associated with gaining access for PCNL, the tradition “bull’s
eye” technique has been reimagined using adjunctive tools to make
the process safer and more efficient. The IPAD-assisted puncture
has been described [23,24], which employs a marker-based tracking
system to achieve access into the collecting system. A preopera-
tive multi-slice CT is obtained in the prone position from which
three-dimensional models based on segmentation of the kidney
and pertinent surrounding structures are rendered. On the operat-
ing table, the iPAD is used to align the three-dimensional models
configured from the CT onto the body of the patient. The virtual
anatomy on the iPAD correlates with the real anatomy and is used
to assess the ideal position for needle puncture. The technique’s fea-
sibility has been studied in three patients followed by a comparative
matched-pair analysis. Safety and efficacy of the technique was sup-
ported, however, there was no significant improvement in puncture
time and radiation exposure. This is attributed to the novelty of and
lack of experience with the technology. Further studies are required
to test the practicality of the method with increased experience and
in combination with tracking of the puncture needle [25].
Additionally, Dyna-CT (Siemens Medical Solutions, Erlangen,
Germany), a digital angiography unit, has been purposed in the
urologic setting. The device produces an image similar to that of a
CT, and segmentation of the imaging allows for a three-dimensional
reconstruction of targeted systems, namely the kidney and collecting
system, via the Artis Zee Celing software. Based on the traditional
“bull’s eye” premise for access, a laser guide (syngo iGuide) marks
the area of puncture on the patient and provides the trajectory for
needle insertion. Ritter et al. [26] recently applied this technique
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hile attempting in  vivo  access in 27 patients. All patients in the
tudy were deemed “complex” access cases in which the ultrasound
ndings were unclear or there was suspicion of injuring nearby
owel. 24 patients had successful percutaneous access obtained with
his technique; there were no major complications noted, however,
he technique employs more radiation that traditional fluoroscopic
ccess and is a time-consuming endeavor. The radiation exposure,
hough, is less with Dyna-CT than with other imaging alternatives
or complex access patients (i.e. CT-guided percutaneous access)
nd improves on locating residual stones during the case.
lectromagnetic tracking (EMT) uses a magnetic field that is gener-
ted around the patient to decipher to the location of ferromagnetic
tructures in  vivo. For percutaneous renal access, a ferromagnetic
ensor tip at the end of a ureteral catheter is endoscopically targeted
nto the calyx into which access is desired. The AURORA tracking
ystem (Waterloo, Canada) is then coupled with the open source
edical Imaging Interaction Toolkit (www.mitk.org) to integrate
nformation of the ureteral catheter sensor and on the access nee-
le via a graphical user interface. Three widgets are used to assist in
eedle placement. Widgets I and II indicate the position and orienta-
ion of the two sensors in a three-dimensional image from differing
amera angles, and Widget III shows the ureteral catheter imaged as
 sphere from the position of the sensor tip needle to better perceive
epth. In a proof-of-principle study, Huber et al. [27] performed
ccess into 90 renal tracts in 6 porcine kidneys with 100% success
ate. 91% of tracts were accessed with a single puncture, whereas the
dditional 9% needed a second puncture. Location of the calyx had
o effect on the success of the technique (p  = 0.64). Access using
his method, however, would be difficult in patient in which retro-
rade calyceal access may be limited due to an obstructing stone or
ignificant stone burden.
long the same concept, Kawahara et al. [28] recently examined the
bility to utilize ureteroscopy to gain renal access. This group uti-
ized a nephrostomy puncture wire through a ureteroscope to achieve
etrograde access into the collecting system. A success rate of 77.3%
s reported using this technique, although there is no comment on
uoroscopy time or the extent of radiation exposure this technique
mploys compared to traditional renal access methods.
osition
ercutaneous nephrolithotomy is most commonly approached from
he prone position. This necessitates a cystoscopy and placement
f a ureteral catheter at the beginning of the procedure in a supine
osition followed by repositioning into the prone position. The pro-
edure can be started with the patient prone and using the less
racticed method of placing a ureteral catheter from this position as
ell. The alternative approach is to perform a PCNL from a supine
osition, thereby allowing access to work from both an anterograde
nd retrograde position simultaneously with ease.
 major criticism of the prone position has involved its safety and
he effects on a patient’s cardiovascular status, especially those
ho are obese. Findings reported by Siev et al. [29], however,
ebut this claim. In 101 patients who underwent prone PCNL, peak
nspiratory pressure (PIP) was measured in both supine and prone
ositions and throughout various time points of the surgery. They
eport obese patients at baseline do have higher PIP values relative
o non-obese patients (p  < 0.01); however, there was no reported
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hange in PIP values in either cohort between supine or prone
ositioning.
here is controversy as to which technique provides the optimal
osition from which to perform a PCNL in terms of operative time,
omplications, and stone-free rates. Findings from the global, multi-
nstitutional CROES study has recently reported on 1311 patients
ho underwent both supine (n  = 232) and prone (n  = 1079) PCNL.
he study found that in patients who underwent a prone PCNL, the
tone-free rate was greater (p  < 0.001), and the operative time was
horter (p  < 0.001). There was no difference in the complication rates
etween the patients who were operated on from either position.
ontrastingly, other studies have examined the differences in posi-
ioning during PCNL as well and have noted that the operative time
s shorter with supine PCNL. Additionally, the literature confirms
imilar complication rates [30–33], transfusion rates and estimated
lood loss [30,32,33], and stone-free rates [30–33] between the two
ositions.
pecial considerations in supine positioning are that the tract with
his access modality is much longer than with prone PCNL, and
onsequentially, the nephroscope is limited from easily traversing
etween calyces. As a result, the use of flexible ureteroscopy is
ndispensable as a tool with which to access the more acutely angled
r inaccessible renal poles. From these areas, stones may be grasped
ith a basket and pulled into the renal pelvis where they may be
efinitively addressed with the nephroscope. We believe that each
osition has its merits and that endourologists should be deft at
erforming PCNL using both modalities.
ract  dilation
onventional tract dilation involves the use of successive graded
mplatz or Alken dilators. Newer methods of dilation involve the
se of balloon dilators that are placed over a wire and rapidly expand
nder pressure in a faster method and one that involves less manip-
lation. Balloon dilation is thought to translate into a less traumatic
ccess and one in which the safety wire is at less risk of becoming
islodged [34]. Given these factors, especially in the obese popu-
ation, use of balloon tract dilators is more common practice than
ore traditional methods [35].
arly models of balloon dilators have been scrutinized because of a
ow burst pressure of 17 ATM. Newer balloon models have improved
n this and can accommodate pressures of 30 ATM before there
s any concern for bursting. The newer generation balloon dilators
ave reported good success rates. Hendlin and Monga [36] surveyed
0 tracts they dilated using a Bard X-force 30 ATM balloon and
xperienced a 100% success rate, a significant improvement over
he 5–10% failure rate reported with standard 17 ATM balloons.
educing the two steps of dilating the access tract and then placing
n access sheath over the dilator into one step, the pathway access
heath (PAS) is a device that allows for tract dilation and sheath
lacement at the same time. Pathak and Bellman [37] compared the
utcomes of the device when compared to a standard balloon dilator.
esults indicated that there is a significantly reduced access time in tract dilated with the PAS system (3.7 min vs. 5.7 min) without a
ignificant increase in cost or estimated blood loss. These findings
re optimistic, but they require study in a larger, prospective trial to
etter confirm these results.
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ephroscopes
he standard rigid nephroscope requires a tract that is dilated to
6–30 F, either via balloon or serial fascial dilation. Given its large
ize, the generous diameter of the scope allows for copious, rapid
ow of irrigation providing excellent visualization and a large visual
eld. The scope is able to accommodate standard PCNL instruments,
ncluding ultrasonic lithotripters and rigid graspers that are effec-
ive in removing large stones efficiently. The 30 F tract allows for
he removal of sizeable stones in one piece, reducing the amount of
lood loss and the time to stone clearance. A standard nephroscope,
owever, has its disadvantages as well. The size of the tract possibly
auses the most renal trauma of any of the alternative options, which
ay lead to a higher risk of intraoperative and postoperative compli-
ations. Traditional PCNL may predispose patients to a higher risk
f operative blood loss, postoperative pseudoaneurysm or arteriove-
ous fistula formation, especially if multiple percutaneous tracts are
eeded for stone clearance.
lexible nephroscopy allows the surgeon to survey calyces within
he kidney that are inaccessible with a single tract obtained with
 standard rigid nephroscope. Using a standard flexible cystoscope
hrough the access tract, residual stones can be identified, removed in
ne piece with a basket, or pulverized with laser lithotripsy before
asket stone extraction. If there is a significant stone burden that
annot be readily reached even with flexible nephroscopy, a sec-
nd tract can be made to remove the residual stone burden. One
hould observe caution when creating a second tract because of the
ncreased risk of bleeding. Although imperfect, in skilled hands,
exible nephroscopy in combination with rigid nephroscopy can
emove a significant stone burden while limiting the number of
ercutaneous tracts needed for the procedure.
maller caliber instruments were originally developed to address
n special situations, like in children or stones in a diverticulum.
ecently smaller and smaller instruments have been developed as
ltrasound and Holmium-YAG-laser lithotripters have improved as
as our understanding of hydrodynamics and stone fragmentation. A
mini”-perc has been coined to describe a PCNL utilizing an access
ract dilated to 12–14 French. This size is large enough to accom-
odate a ureteral sheath and both flexible and rigid ureteroscopic
nstruments. A pediatric cystoscope can be used in addition to a 12
rench rigid nephroscope. Li et al. [38] has described an irrigation
ethod of effectively clearing stone fragments using these smaller
copes. An endoscopic pulsed perfusion pump is combined with
etrograde pressurized flushes of the collecting system using a pre-
iously placed ureteral catheter. The pump irrigating through the
ndoscope generates a pressure increase up to 300 mmHg for 3 sec-
nd intervals interrupted with 2 s of rest. The 2 irrigation modalities
istend the collecting system, and when properly timed, the removal
f the endoscope creates a vacuum within the sheath, forcing out
maller fragments. A concern with this irrigation method is the risk
or pyelovenous backflow. Guohua et al. [39] in studying this device
oted that the intra-renal pressures that developed were in fact lower
han those required for pyelovenous backflow. In addition, when the
eak pressure was reached, it was not sustained, and as the fluid was
vacuated, the pressure was soon relieved.ndicated for stones <2 cm in their greatest dimension, the mini-perc
as some advantages over the standard PCNL. The smaller tract it
tilizes has the potential to cause less renal trauma and therefore
uggests a lower risk of bleeding both during the procedure and
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afterwards. A smaller tract may also decrease the amount of narcotic
pain medicine the patient requires post-operatively and the length
of hospital stay. Disadvantages of the smaller tract include poorer
visualization of the collecting system and therefore less efficient
stone lithotripsy. The decreased size of the working channel limits
the type of instruments that can be utilized including lasers, baskets,
small suction devices, and small grasping forceps.
The combination of the standard and the mini-perc together may
provide more efficient means by which to maximize stone free
rates in patients with staghorn calculi or significant stone burden.
In patients who require a second access channel, a smaller tract
provided by the mini-perc can assist in minimizing trauma and
bleeding. Wang et al. [40] evaluated a standard PCNL cohort with a
PCNL/mini-perc group showing a greater likelihood of developing
stone free rates with the PCNL/mini-perc. Rates of operative time,
complication time, and reoperation rate were similar between the
two groups.
Even finer than the mini-perc is the “micro”-perc designed to work
with an even smaller channel. Micro-PCNL employs a 4.85 F optic
needle, named the “all-seeing needle”, that was first designed as a
method of more efficiently obtaining calyceal access prior to dila-
tion. Given the access needle itself provides images to guide the case
and, there is no need for dilation, thus obviating the risk of accruing
the complications with which it is associated [41]. Because of the
small size of the micro-PCNL instrumentation, it is best suited for
small and moderate sized stones. This PCNL modality has unique
advantages. It is most useful for stones that are difficult to access
ureteroscopically and in lower pole stones that have a poor clearance
rates with ESWL.
Lithotripsy
There are an array of options for intracorporeal lithotripsy that
can be used with PCNL. The most commonly used devices are
the Holmium:YAG laser, pneumatic and ultrasonic lithotripter, or
devices that combine each of these technologies. Each modality has
its advantages, and all are safe, causing limited damage to the native
tissue during use.
As stand-alone devices, ultrasonic lithotripters are the most efficient
for clearing stones and historically the most favored devices. They
have the ability to simultaneously fragment and clear stones less
than 2 mm through their suction apparatus [42]. Despite pneumatic
lithotripters being more powerful and effective at breaking hard
stones than ultrasonic lithotriptors, they cause a significant amount
of retropulsion that disperses the fragment of varying sizes through-
out the collecting system. Thus, the time required to retrieve and
clear the migrated stone fragments from distant calyces decreases
the efficacy of stone clearance of these devices [43]. The least
efficient method for clearing stones is laser lithotripsy. El-Nahas
and associates [44] compared of high powered holmium laser use
(2 J, 20–30 Hz) to ultrasonic lithotripsy during PCNL for complete
staghorn calculi and showed that use of the laser leads to a sig-
nificantly longer operative time (148 vs. 130 min, p  = 0.03) with
no change in postoperative complications or stone free rates at
3 months of follow-up. In contrast to its poorer efficiency, the
laser’s unique advantage over the other methods is its flexibility.
It can be used to address stones during flexible ureteroscopy or
nephroscopy.
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he most modern lithotriptors combine multiple lithotripsy tech-
ologies and have been shown to significantly improve the efficiency
f stone clearance than either modality by itself [45]. As such, they
re the most commonly used devices for intracorporeal lithotripsy in
CNL. Popular examples include the CyberWand (Olympus Corpo-
ation, Tokyo, Japan) – a dual probe ultrasonic lithotripter and the
ithoClast Select (Boston Scientific, Marlborough, MA) – a dual
ltrasonic and pneumatic lithotripter. Currently, there is a lack of
vidence showing the superiority of one combination device over
nother [46].
ew developments in intracorporal lithotripsy aim to further
mprove on the efficiency of stone clearance. One novel device is the
ercSac, a polyethylene sack used to ensnare the stone and contain
ll of its fragments during lithotripsy. In in  vitro  models, the device
as been shown to improve stone fragmentation efficiency and stone
learance rates [47]. Recently, The UreTron (Med-Sonics, Eerie,
A), a new single probe ultrasonic lithotriptor, received Food and
rug Administration (FDA) approval for use in the United States.
his device employs improved vibratory and control features that
nlike previous generations of ultrasonic lithotripters is aimed at
mproving performance in pulverizing all types of stones without
ompromising suction. In an initial study of the device, Borofsky
t al. [48] showed improved stone clearance rates using the UreTron
ompared to dual probe lithotripters (51.0 vs. 36 mm2/min, p  = 0.02)
ith no change in postoperative complications or outcomes.
xit  strategies
tandard drainage of the kidney at the end of a PCNL involves leav-
ng a nephrostomy tube in place. Over time, the caliber of these tubes
as decreased with a subset of patients being left tubeless altogether.
hese drainage methods can be separated into three different types:
arge nephrostomy tubes, small nephrostomy tubes, and a “tubeless”
pproach involving the placement of only a ureteral catheter at the
nd of the procedure.
he most common nephrostomy tube used is a 24 F malecot re-
ntry nephrostomy tube. The tube is positioned within the access
ract. Its size provides a tamponade effect to minimize bleeding
nd a low pressure conduit through which the kidney may drain.
he drain is held in position by the malecot tip that rests in the
enal pelvis. The tapered, most distal ureteral portion allows for the
assage of a wire into the bladder with ease for through-and-through
ccess. This advantage is exceedingly helpful in patients in which
taging or reoperation is necessary, with significant blood loss, when
ignificant stone burden must be left at the end of the case, or in a
atient with complex anatomy [49].
ompared to the 24 French re-entry tubes, smaller nephrostomy
ubes have been associated with lower postoperative pain levels, and
esultantly they have been explored as a more ideal alternative [50].
hese alternate tubes vary in size from 8–14 F, and after uncompli-
ated cases, these smaller tubes are viewed as a safe alternative for
rainage.
 “tubeless” PCNL is another safe, viable option for avoiding place-
ent of an external drainage tube. This is performed by leaving a
reteral catheter and a Foley catheter. A “modified tubeless” PCNL
s one in which instead of a ureteral catheter, a double-J ureteral
tent and Foley catheter are left after surgery. With the latter tubeless
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ethod, the Foley catheter is removed on the first day after surgery,
hile the ureteral stent is removed 5–10 days later. With the for-
er true tubeless method, both the ureteral catheter and the Foley
atheter are removed 24–48 h after surgery. The outcomes using
ubeless PCNL in straightforward, uncomplicated cases have been
xtremely favorable. Zilberman et al. [51] studied the tubeless PCNL
echnique and noted that patients undergoing this procedure neces-
itated a decreased amount of narcotic pain medication, experienced
 shorter hospital stay, and had a reduced duration of recovery com-
ared to a standard PCNL without any increase in complications.
n an effort to promote hemostasis and reduce the amount of urinary
xtravasation, tract sealants have been utilized in the final stages of
ubeless PCNLs in lieu of nephrostomy tubes. Examples of these
ompounds applied to calyceal tracts include fibrin glue and FloSeal,
owever, the efficacy of these products is debatable. In a prospective
andomized trial assessing the use of fibrin sealant after PCNL to a
ontrol arm without any sealant, there was no difference in rates of
lood transfusion. In addition, although there was a trend toward less
ostoperative pain and analgesic requirement in the sealant cohort,
he results were not significant [52].
ike tract sealants, cryotherapy has also been proposed to facilitate
mproved outcomes with tubeless PCNL. Okeke et al. [53] used the
echnique to freeze the renal parenchyma outside the collecting sys-
em using a cryoprobe. A 10-min freeze/thaw cycle was performed
efore the skin incision was closed. Results indicated that cryother-
py of the surgical tracts shortened the length of hospital stay and
educed the rate of delayed bleeding and urinary leaks.
he optimal methods of calyceal drainage after a mini-perc have also
een contested. Sabnis et al. [54] conducted a randomized controlled
rial examining three different exit strategy options: a modified tube-
ess option with a double-J stent and a Foley catheter, a tubeless
ption with a ureteral catheter and a Foley catheter, or a tubed option
ith a 14 F nephrostomy tube, ureteral catheter, and Foley catheter.
esults indicated that the patients best tolerated tubeless procedures
n which a ureteral catheter and Foley catheter were left in place.
here was no difference in the drop in hematocrit, rates of urine
eak, or perioperative complications between the three groups.
ostoperative  antibiotics
here is no concrete evidence to support a guideline on the type of or
uration of antibiotic therapy after PCNL. In patients who have posi-
ive urine or stone cultures, the antibiotic of choice should be tailored
o the offending organism that can be identified. If a patient develops
epsis, he/she should be treated based on pre-established clinical
uidelines without change in management based on the source
f the infection. Current American Urological Association (AUA)
uidelines recommend a perioperative prophylactic antibiotic dose
ollowed by an additional 24 h of antibiotics. Some consideration
s given to extending the antibiotics course when manipulating an
ndwelling Foley catheter or nephrostomy tube [55].
onclusionshe techniques involved in percutaneous stone surgery are
onsistently changing in a direction to improve both the ease of
onducting these procedures as well as reducing the morbidity with
hich they are associated. Although there are a variety of promising
[S. Derisavifard et al.
echnologies, many require further study to assess if they are of
ny significant benefit and may provide a cost-effective alternative
o current standards of care. It is imperative that urologic surgeons
erforming these procedures be familiar with these advancements
n order to assess if any new developments would be suitable to
ncorporate into their practices to improve patient outcomes.
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